Annual Revenue
$249.38 M
+$45.34 M+22.22%
December 31, 2023
Summary
- As of February 7, 2025, BPMC annual revenue is $249.38 million, with the most recent change of +$45.34 million (+22.22%) on December 31, 2023.
- During the last 3 years, BPMC annual revenue has fallen by -$544.36 million (-68.58%).
- BPMC annual revenue is now -68.58% below its all-time high of $793.74 million, reached on December 31, 2020.
Performance
BPMC Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$128.18 M
-$9.97 M-7.22%
September 30, 2024
Summary
- As of February 7, 2025, BPMC quarterly revenue is $128.18 million, with the most recent change of -$9.97 million (-7.22%) on September 30, 2024.
- Over the past year, BPMC quarterly revenue has increased by +$71.62 million (+126.61%).
- BPMC quarterly revenue is now -82.80% below its all-time high of $745.12 million, reached on September 30, 2020.
Performance
BPMC Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$434.41 M
+$71.62 M+19.74%
September 30, 2024
Summary
- As of February 7, 2025, BPMC TTM revenue is $434.41 million, with the most recent change of +$71.62 million (+19.74%) on September 30, 2024.
- Over the past year, BPMC TTM revenue has increased by +$218.21 million (+100.93%).
- BPMC TTM revenue is now -47.54% below its all-time high of $828.10 million, reached on June 30, 2021.
Performance
BPMC TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
BPMC Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.2% | +126.6% | +100.9% |
| 3 y3 years | -68.6% | +122.7% | +92.5% |
| 5 y5 years | +460.1% | +122.7% | +92.5% |
BPMC Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.5% | -7.2% | +250.7% | at high | +141.2% |
| 5 y | 5-year | -68.6% | +274.9% | -82.8% | +1978.5% | -47.5% | +553.1% |
| alltime | all time | -68.6% | +2087.5% | -82.8% | >+9999.0% | -47.5% | >+9999.0% |
Blueprint Medicines Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $128.18 M(-7.2%) | $434.41 M(+19.7%) |
| Jun 2024 | - | $138.16 M(+43.7%) | $362.80 M(+28.6%) |
| Mar 2024 | - | $96.12 M(+33.6%) | $282.21 M(+13.2%) |
| Dec 2023 | $249.38 M(+22.2%) | $71.96 M(+27.2%) | $249.38 M(+15.3%) |
| Sep 2023 | - | $56.57 M(-1.7%) | $216.20 M(-4.2%) |
| Jun 2023 | - | $57.57 M(-9.0%) | $225.62 M(+10.3%) |
| Mar 2023 | - | $63.29 M(+63.2%) | $204.59 M(+0.3%) |
| Dec 2022 | $204.04 M(+13.3%) | $38.78 M(-41.2%) | $204.04 M(-25.1%) |
| Sep 2022 | - | $65.98 M(+80.5%) | $272.28 M(+18.1%) |
| Jun 2022 | - | $36.55 M(-41.7%) | $230.49 M(+4.2%) |
| Mar 2022 | - | $62.73 M(-41.4%) | $221.24 M(+22.9%) |
| Dec 2021 | $180.08 M(-77.3%) | $107.02 M(+342.5%) | $180.08 M(+68.0%) |
| Sep 2021 | - | $24.19 M(-11.4%) | $107.17 M(-87.1%) |
| Jun 2021 | - | $27.30 M(+26.5%) | $828.10 M(+2.3%) |
| Mar 2021 | - | $21.58 M(-36.7%) | $809.14 M(+1.9%) |
| Dec 2020 | $793.74 M(+1093.4%) | $34.11 M(-95.4%) | $793.73 M(-2.1%) |
| Sep 2020 | - | $745.12 M(+8831.1%) | $811.16 M(+978.9%) |
| Jun 2020 | - | $8.34 M(+35.3%) | $75.18 M(+4.5%) |
| Mar 2020 | - | $6.17 M(-88.0%) | $71.95 M(+8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $66.51 M(+49.4%) | $51.53 M(+463.9%) | $66.51 M(+315.4%) |
| Sep 2019 | - | $9.14 M(+78.8%) | $16.01 M(+101.0%) |
| Jun 2019 | - | $5.11 M(+600.0%) | $7.97 M(-82.0%) |
| Mar 2019 | - | $730.00 K(-29.3%) | $44.30 M(-0.5%) |
| Dec 2018 | $44.52 M(+107.8%) | $1.03 M(-5.7%) | $44.52 M(-1.3%) |
| Sep 2018 | - | $1.09 M(-97.4%) | $45.12 M(-13.4%) |
| Jun 2018 | - | $41.44 M(+4243.7%) | $52.09 M(+214.9%) |
| Mar 2018 | - | $954.00 K(-41.4%) | $16.54 M(-22.8%) |
| Dec 2017 | $21.43 M(-22.9%) | $1.63 M(-79.8%) | $21.43 M(-22.1%) |
| Sep 2017 | - | $8.07 M(+37.0%) | $27.49 M(+7.5%) |
| Jun 2017 | - | $5.89 M(+0.9%) | $25.58 M(-4.4%) |
| Mar 2017 | - | $5.84 M(-24.1%) | $26.76 M(-3.7%) |
| Dec 2016 | $27.77 M(+143.6%) | $7.69 M(+24.9%) | $27.77 M(+12.4%) |
| Sep 2016 | - | $6.16 M(-12.8%) | $24.72 M(+12.4%) |
| Jun 2016 | - | $7.07 M(+3.0%) | $21.98 M(+24.9%) |
| Mar 2016 | - | $6.86 M(+47.9%) | $17.60 M(+54.4%) |
| Dec 2015 | $11.40 M | $4.63 M(+35.3%) | $11.40 M(+68.5%) |
| Sep 2015 | - | $3.43 M(+27.5%) | $6.76 M(+102.6%) |
| Jun 2015 | - | $2.69 M(+312.1%) | $3.34 M(+412.1%) |
| Mar 2015 | - | $652.00 K | $652.00 K |
FAQ
- What is Blueprint Medicines annual revenue?
- What is the all time high annual revenue for Blueprint Medicines?
- What is Blueprint Medicines annual revenue year-on-year change?
- What is Blueprint Medicines quarterly revenue?
- What is the all time high quarterly revenue for Blueprint Medicines?
- What is Blueprint Medicines quarterly revenue year-on-year change?
- What is Blueprint Medicines TTM revenue?
- What is the all time high TTM revenue for Blueprint Medicines?
- What is Blueprint Medicines TTM revenue year-on-year change?
What is Blueprint Medicines annual revenue?
The current annual revenue of BPMC is $249.38 M
What is the all time high annual revenue for Blueprint Medicines?
Blueprint Medicines all-time high annual revenue is $793.74 M
What is Blueprint Medicines annual revenue year-on-year change?
Over the past year, BPMC annual revenue has changed by +$45.34 M (+22.22%)
What is Blueprint Medicines quarterly revenue?
The current quarterly revenue of BPMC is $128.18 M
What is the all time high quarterly revenue for Blueprint Medicines?
Blueprint Medicines all-time high quarterly revenue is $745.12 M
What is Blueprint Medicines quarterly revenue year-on-year change?
Over the past year, BPMC quarterly revenue has changed by +$71.62 M (+126.61%)
What is Blueprint Medicines TTM revenue?
The current TTM revenue of BPMC is $434.41 M
What is the all time high TTM revenue for Blueprint Medicines?
Blueprint Medicines all-time high TTM revenue is $828.10 M
What is Blueprint Medicines TTM revenue year-on-year change?
Over the past year, BPMC TTM revenue has changed by +$218.21 M (+100.93%)